Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Blue cone monochromacy with parafoveal hyperautofluorescent ring caused by a novel OPN1LW p.Ile109Asn variant.

Documenta ophthalmologica. Advances in ophthalmology·2026
Same author

Gene therapy rescues cone function in an all-cone retina mouse model with the most common cone opsin C203R missense mutation.

PloS one·2026
Same author

Gene therapy rescues cone function in <i>opn1mw</i> <sup>-/-</sup> <i>/opn1sw</i> <sup>-/-</sup> <i>/Nrl</i> <sup>-/-</sup> mice, an all-cone model of blue cone monochromacy.

Molecular therapy. Advances·2026
Same author

Laterally spreading AAV.SPR enables safe and efficient RS1 delivery to the macula after peripheral subretinal injection.

Molecular therapy : the journal of the American Society of Gene Therapy·2026
Same author

Monitoring outcomes of the first human whole eye allotransplant.

Documenta ophthalmologica. Advances in ophthalmology·2026
Same author

Correction: Inhibitor of Apoptosis-Stimulating Protein of p53 (iASPP) Is Required for Neuronal Survival after Axonal Injury.

PloS one·2026

相关实验视频

Updated: Jul 28, 2025

Laser-scanning Photostimulation of Optogenetically Targeted Forebrain Circuits
07:43

Laser-scanning Photostimulation of Optogenetically Targeted Forebrain Circuits

Published on: December 27, 2013

9.3K

使用光遗传基因疗法恢复视觉功能的临床可行的方法.

Boyuan Yan1,2, Suresh Viswanathan3, Scott E Brodie4

  • 1Department of Physiology and Biophysics, Weill Cornell Medicine, New York, NY 10065, USA.

Molecular therapy. Methods & clinical development
|May 30, 2023
PubMed
概括
此摘要是机器生成的。

使用Chronos的光遗传基因疗法显示出在视网膜疾病中恢复视力的前景. 临床前研究证实了动物模型中的疗效和安全性,支持对视网膜色素炎的临床试验.

关键词:
光遗传基因疗法是一种光遗传基因疗法.临床前研究的临床前研究.视网膜假体是一种视网膜假体.视网膜炎的颜色化视力恢复视力恢复

更多相关视频

Methodology for Biomimetic Chemical Neuromodulation of Rat Retinas with the Neurotransmitter Glutamate In Vitro
12:56

Methodology for Biomimetic Chemical Neuromodulation of Rat Retinas with the Neurotransmitter Glutamate In Vitro

Published on: December 19, 2017

7.8K
Injections of AAV Vectors for Optogenetics in Anesthetized and Awake Behaving Non-Human Primate Brain
09:42

Injections of AAV Vectors for Optogenetics in Anesthetized and Awake Behaving Non-Human Primate Brain

Published on: August 4, 2021

3.7K

相关实验视频

Last Updated: Jul 28, 2025

Laser-scanning Photostimulation of Optogenetically Targeted Forebrain Circuits
07:43

Laser-scanning Photostimulation of Optogenetically Targeted Forebrain Circuits

Published on: December 27, 2013

9.3K
Methodology for Biomimetic Chemical Neuromodulation of Rat Retinas with the Neurotransmitter Glutamate In Vitro
12:56

Methodology for Biomimetic Chemical Neuromodulation of Rat Retinas with the Neurotransmitter Glutamate In Vitro

Published on: December 19, 2017

7.8K
Injections of AAV Vectors for Optogenetics in Anesthetized and Awake Behaving Non-Human Primate Brain
09:42

Injections of AAV Vectors for Optogenetics in Anesthetized and Awake Behaving Non-Human Primate Brain

Published on: August 4, 2021

3.7K

科学领域:

  • 眼科医生 眼科 眼科
  • 基因治疗 基因治疗
  • 神经科学是一个神经科学.

背景情况:

  • 视网膜退行性疾病,如视网膜色素炎 (RP),导致视力丧失.
  • 光遗传基因疗法是恢复视力的潜在策略.
  • 几项临床试验正在研究光遗传学方法.

研究的目的:

  • 为NCT04278131临床试验提供临床前有效性和安全性数据.
  • 为了评估输送Chronos光遗传蛋白的腺相关病毒血清型2 (AAV2) 载体.

主要方法:

  • 在小鼠中使用剂量依赖电网红图 (ERG) 评估了疗效.
  • 在老鼠,非人类灵长类动物和小鼠中评估了安全性.
  • 安全性评估包括免疫组织化学,细胞计数,ERG和眼部毒理学测试.

主要成果:

  • 克罗诺斯表达载体在各种剂量和光强度中表现出有效性.
  • 在解剖学或电生理学测试中没有观察到与测试物品相关的不良发现.
  • 基因治疗方法在所有动物模型中都能耐受.

结论:

  • 临床前数据支持AAV2-Chronos在视力恢复方面的安全性和有效性.
  • 这种方法有可能用于治疗视网膜退行性疾病的患者.
  • 这些发现鼓励对人类进行进一步的临床研究.